ELV vs HUM — Key Metrics
| Metric | ELV (ELEVANCE HEALTH INC) | HUM (HUMANA INC) |
|---|---|---|
| Price | 388.82 | 381.57 |
| Market Cap | 84.32 Billion | 45.82 Billion |
| P/E (TTM) | 17.17 | 35.83 |
| P/B (Quarterly) | 1.886 | 2.284 |
| P/S (TTM) | 0.42 | 0.31 |
| Net Profit Margin (TTM) | 2.5 | 0.9 |
| Gross Margin (TTM) | 15.1 | 13.7 |
| ROE (TTM) | 11.2 | 6.9 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
ELV · ELEVANCE HEALTH INC
Outperform
HUM · HUMANA INC
Greatly Outperform
Recommendation Summary
Stock ELV is projected to outperform the market, stock HUM is projected to greatly outperform the market. Upfront Recommendation: HUM.
Financial Metrics
Prices delayed ~15 min
| ELV | Metrics | HUM |
|---|---|---|
| $388.82 | Price | $381.57 |
| — | Market Capitalization | — |
| 17.17 | Price to Earnings Ratio | 35.83 |
| 0.42 | Price to Sales | 0.31 |
| 13.41 | Price to FCF Ratio | 23.23 |
| 2.77 | Price to Gross Profit | 2.3 |
| 1.26 | Price to Current Assets | 1.14 |